Gp Act Iii Acquisition Stock Today

GPAT Stock   10.57  0.03  0.28%   

Performance

Solid

 
Weak
 
Strong

Odds Of Distress

Below Average

 
High
 
Low
GP Act is selling for under 10.57 as of the 23rd of June 2025; that is 0.28 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 10.52. GP Act has about a 38 percent probability of financial distress in the next few years of operation but had a somewhat solid performance during the last 90 days. The performance scores are derived for the period starting the 25th of March 2025 and ending today, the 23rd of June 2025. Click here to learn more.
Business Domain
Financial Services
IPO Date
1st of July 2024
Classification
Financials
GP Act is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 28.75 M outstanding shares of which 1.63 K shares are currently shorted by private and institutional investors with about 0.01 trading days to cover. More on GP Act III Acquisition

Moving together with GPAT Stock

  0.73V Visa Class APairCorr
  0.64DIST Distoken AcquisitionPairCorr
  0.72AB AllianceBernsteinPairCorr
  0.78BN Brookfield CorpPairCorr

Moving against GPAT Stock

  0.82PT Pintec TechnologyPairCorr
  0.61RM Regional Management CorpPairCorr
  0.6RC Ready Capital CorpPairCorr
  0.49LX Lexinfintech HoldingsPairCorr
  0.49PX P10 IncPairCorr

GPAT Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Business ConcentrationDiversified Financial Services, Financial Services, NASDAQ Composite, Financials, Financial Services, Financial Services, Financial Services (View all Sectors)
Debt Levels
GP Act can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand GP Act's financial leverage. It provides some insight into what part of GP Act's total assets is financed by creditors.
Liquidity
GP Act III Acquisition currently holds 400 K in liabilities. Note, when we think about GP Act's use of debt, we should always consider it together with its cash and equity.

Change In Working Capital

(18,757.75)
GP Act III Acquisition (GPAT) is traded on NASDAQ Exchange in USA. It is located in 300 Park Avenue, New York, NY, United States, 10022 and employs 2 people. GP Act is listed under Diversified Financial Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 379.86 M. GP Act III conducts business under Financial Services sector and is part of Financials industry. The entity has 28.75 M outstanding shares of which 1.63 K shares are currently shorted by private and institutional investors with about 0.01 trading days to cover. GP Act generates negative cash flow from operations
Check GP Act Probability Of Bankruptcy
Ownership Allocation
GP Act III secures a total of 28.75 Million outstanding shares. The majority of GP Act III outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to purchase positions in GP Act III Acquisition to benefit from reduced commissions. Hence, outside corporations are subject to a different set of regulations than regular investors in GP Act III. Please pay attention to any change in the institutional holdings of GP Act as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check GPAT Ownership Details

GP Act Historical Income Statement

At this time, GP Act's Other Operating Expenses is comparatively stable compared to the past year. EBITDA is likely to gain to about 9.1 M in 2025, despite the fact that Operating Income is likely to grow to (536.8 K). View More Fundamentals

GPAT Stock Against Markets

Additional Tools for GPAT Stock Analysis

When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.